Search

Your search keyword '"Morra, V."' showing total 853 results

Search Constraints

Start Over You searched for: Author "Morra, V." Remove constraint Author: "Morra, V."
853 results on '"Morra, V."'

Search Results

3. Sexual dysfunction in multiple sclerosis: the impact of different MSISQ-19 cut-offs on prevalence and associated risk factors

4. Do patients’ and referral centers’ characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register

8. Clinical validation in multiple sclerosis of the lumipulse immunoassay for plasma neurofilament light chain

11. Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry

12. Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register

17. Utilization of peginterferon-β-1a in the real-world practice for relapsing-remitting multiple sclerosis.

18. Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients with Primary Progressive Multiple Sclerosis

19. Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register

20. Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register

22. Signs and symptoms of COVID-19 in patients with multiple sclerosis

23. MR Imaging Signs of Gadolinium Retention Are Not Associated with Long-Term Motor and Cognitive Outcomes in Multiple Sclerosis

27. Signals of pseudo-starvation unveil the amino acid transporter SLC7A11 as key determinant in the control of Treg cell proliferative potential

28. Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register

29. Risk of Persistent Disability in Patients with Pediatric-Onset Multiple Sclerosis

32. JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level

33. Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis

34. Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration

35. Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis

36. The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis

37. Signs and symptoms of COVID-19 in patients with multiple sclerosis

38. SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study

41. The petrology and geochemistry of Nyiragongo lavas of 2002, 2016, 1977 and 2017 AD, and the trace element partitioning between melilitite glass and melilite, nepheline, leucite, clinopyroxene, apatite, olivine and Fe-Ti oxides: a unique scenario

43. The Italian multiple sclerosis register

44. Preliminary results of the FASM study, an on-going italian active pharmacovigilance project

49. A Combined Radiomics and Machine Learning Approach to Overcome the Clinicoradiologic Paradox in Multiple Sclerosis

50. Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis

Catalog

Books, media, physical & digital resources